Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
-3M
-
Total reported value, excl. options
-
$141M
-
Value change
-
-$12.5M
-
Put/Call ratio
-
0.13
-
Number of buys
-
50
-
Number of sells
-
-55
-
Price
-
$4.67
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2025
133 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2025.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
of 55.5M outstanding shares and own 54.45% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.61M shares), ARMISTICE CAPITAL, LLC (4.2M shares), VANGUARD GROUP INC (3.25M shares), MILLENNIUM MANAGEMENT LLC (2.29M shares), Vestal Point Capital, LP (1.48M shares), DIMENSIONAL FUND ADVISORS LP (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (1.15M shares), Erste Asset Management GmbH (1.12M shares), STATE STREET CORP (925K shares), and EcoR1 Capital, LLC (670K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.